Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference
Collegium Pharmaceutical EVP Sells COLL 17,600 Shares Amid Strong Close of 2025 [Yahoo! Finance]
Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now? [Yahoo! Finance]
Will Authorized Generic Nucynta Launch and New Credit Facility Change Collegium Pharmaceutical's (COLL) Narrative? [Yahoo! Finance]
Is It Time To Reassess Collegium Pharmaceutical (COLL) After Its Strong Five Year Share Price Run? [Yahoo! Finance]